Bought more Novo Nordisk shares (in rollercoaster week)
Greedy while others are fearful
I invest each week and write about it here.
I started just a few weeks back, so this is my third buy. Last week I invested in Novo Nordisk. Europe’s biggest company at the time.
What a week it’s been.
Down 10, up 15
A day after the initial purchase, Novo ends up in the news. Not in a good way. The US decided to review Novo prices.
The share dropped about 10% over a couple of trading sessions.
And Novo got dethroned. Market cap fell so much that Louis Vuitton overtook Novo as Europe’s largest company. Très triste.
Shares climbed back a bit midweek. 5% or so. And then today, a surge. Up some 11% already on positive results from a new drug trial.
Très bien. What a start with Novo.
Fearful
As an investor, of course an immediate price drop worried me. Luckily not that much.
A lot of people are concerned Novo will get hit. Hit by tariffs, hit by a downturn, hit by competition. Probably with good reason.
But I saw this as a chance to stay greedy while others are fearful.
There’s so much good going on in the numbers of that company. The return on capital, growth prospects, low debt and wads of cash.
I saw the drop as another buying opportunity and picked up a bit more before market open today. (Purchased at around 580 Danish kronor).
Results
The result is I’m now up nearly 10% in one week on Novo. Not a big deal. It’s all very long-term. So one week is nothing. But I feel good about a couple things:
Actually buying more when prices go down. There’s a difference between theory. Ie knowing you should buy when something is lower. And practice. Ie actually buying more after a big drop.
Keeping my focus and not buying something new. Of course I looked closely at a lot of other companies this week. But Novo remained at the top of my list. Glad I kept my eye on the ball.
Total performance
In this newsletter, I also plan to report on total performance. After three weeks, it looks like this. About one-third Investor, up about 5% and two-thirds Novo, up 9%.
Very fun so far on this rollercoaster.
Thanks for reading. Let me know what you think. And follow along.
Joel Sherwood invests each week and writes about what he buys, learns and earns. He’s a former financial journalist for Dow Jones and The Wall Street Journal, and a current bank employee. He lives in Stockholm, Sweden and started the Sherwood Investment Letter in January 2025. Purchases are not recommendations.